scholarly article | Q13442814 |
P356 | DOI | 10.1111/TRI.12919 |
P698 | PubMed publication ID | 28109023 |
P50 | author | Vaihere Delaune | Q87668078 |
Christian Toso | Q89461410 | ||
P2093 | author name string | Thierry Berney | |
Stéphanie Lacotte | |||
P2860 | cites work | Innate immunity and intestinal microbiota in the development of Type 1 diabetes | Q24647312 |
Bacteroides: the good, the bad, and the nitty-gritty | Q24685642 | ||
Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation | Q28201202 | ||
Intestinal microbial variation may predict early acute rejection after liver transplantation in rats | Q28654475 | ||
Tolerance, danger, and the extended family | Q29547532 | ||
Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site | Q31879740 | ||
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats | Q33864397 | ||
Hyperbaric oxygen therapy improves early posttransplant islet function | Q34040039 | ||
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes | Q34091887 | ||
Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation | Q34121789 | ||
Interactions between hepatic stellate cells and the immune system | Q34391394 | ||
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes | Q34668698 | ||
Graft vascular function after transplantation of pancreatic islets | Q34728192 | ||
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice | Q34813756 | ||
Dendritic cells and immune regulation in the liver | Q35043807 | ||
Long term effect of gut microbiota transfer on diabetes development | Q35157830 | ||
Increased numbers of low-oxygenated pancreatic islets after intraportal islet transplantation | Q35179990 | ||
Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways | Q35364286 | ||
Islet preconditioning via multimodal microfluidic modulation of intermittent hypoxia | Q35828055 | ||
The role of the intestinal microbiota in type 1 diabetes mellitus | Q35884681 | ||
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts | Q36053215 | ||
Rapid Restoration of Vascularity and Oxygenation in Mouse and Human Islets Transplanted to Omentum May Contribute to Their Superior Function Compared to Intraportally Transplanted Islets. | Q36056471 | ||
Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantation | Q36495202 | ||
Fecal microbiota composition differs between children with β-cell autoimmunity and those without | Q36720600 | ||
Protection of islet grafts through transforming growth factor-β-induced tolerogenic dendritic cells. | Q37110557 | ||
Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation | Q37217407 | ||
Optimal implantation site for pancreatic islet transplantation | Q37320025 | ||
Current advances and travails in islet transplantation | Q37360411 | ||
Is the origin of type 1 diabetes in the gut? | Q37980043 | ||
Cell-Permeable Peptide Blocks TLR4 Signaling and Improves Islet Allograft Survival | Q38803353 | ||
Liver sinusoidal endothelial cells: Physiology and role in liver diseases. | Q38898820 | ||
Immune protective effect of human alpha-1-antitrypsin gene during β cell transplantation in diabetic mice | Q38899884 | ||
High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice | Q39251198 | ||
Liver natural killer cells play a role in the destruction of islets after intraportal transplantation | Q39578486 | ||
A Retrievable, Efficacious Polymeric Scaffold for Subcutaneous Transplantation of Rat Pancreatic Islets | Q39590555 | ||
Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia | Q40435647 | ||
Transplant Site Influences the Immune Response After Islet Transplantation: Bone Marrow Versus Liver | Q40558223 | ||
Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. | Q41788479 | ||
Effect of nicotinamide on early graft failure following intraportal islet transplantation | Q42228583 | ||
Attenuation of cross-talk between the complement and coagulation cascades by C5a blockade improves early outcomes after intraportal islet transplantation | Q42768734 | ||
C5a-Inhibitory Peptide Combined with Gabexate Mesilate Prevents the Instant Blood-Mediated Inflammatory Reaction in a Rat Model of Islet Transplantation | Q42943629 | ||
Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation | Q42975901 | ||
Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success | Q43153441 | ||
Bone marrow as an alternative site for islet transplantation. | Q43272811 | ||
Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation | Q43278827 | ||
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation | Q43833546 | ||
Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation | Q44007209 | ||
Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets | Q44493618 | ||
Changes in liver enzymes after clinical islet transplantation | Q44662210 | ||
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice | Q45163956 | ||
The portal immunosuppressive storm: relevance to islet transplantation? | Q45234964 | ||
Positron-emission tomography imaging of early events after transplantation of islets of Langerhans | Q45256587 | ||
Transaminitis after pancreatic islet transplantation | Q45287503 | ||
Improvement of rat islet viability during transplantation: validation of pharmacological approach to induce VEGF overexpression | Q45866833 | ||
Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation | Q45868552 | ||
Prevention of early loss of transplanted islets in the liver of mice by adenosine. | Q45936359 | ||
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. | Q45981052 | ||
CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice | Q46454884 | ||
Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade. | Q46822274 | ||
Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation | Q46903624 | ||
Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning | Q46909266 | ||
Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model | Q46913106 | ||
Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets | Q47425897 | ||
Time course and quantification of pancreatic islet revascularization following intraportal transplantation | Q48904792 | ||
Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition. | Q51089444 | ||
Ischemic preconditioning improves islet recovery after pancreas cold preservation. | Q51794380 | ||
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? | Q52536571 | ||
Hepatic stellate cells induce immunotolerance of islet allografts. | Q53041510 | ||
Rapamycin, a specific inhibitor of the target of rapamycin complex 1, disrupts intestinal barrier integrity in broiler chicks. | Q53388842 | ||
Characterization of Innate Immunity in an Extended Whole Blood Model of Human Islet Allotransplantation. | Q53463922 | ||
Composite islet-endothelial cell grafts: a novel approach to counteract innate immunity in islet transplantation. | Q53654471 | ||
P433 | issue | 3 | |
P304 | page(s) | 227-238 | |
P577 | publication date | 2017-01-21 | |
P1433 | published in | Transplant International | Q15762140 |
P1476 | title | Intraportal islet transplantation: the impact of the liver microenvironment | |
P478 | volume | 30 |
Q93192279 | A novel model for in vivo quantification of immediate liver perfusion impairment after pancreatic islet transplantation |
Q91845584 | Characterization of the Effects of Mesenchymal Stromal Cells on Mouse and Human Islet Function |
Q64325780 | Extra-Hepatic Islet Transplantation: Validation of the h-Omental Matrix Islet filliNG (hOMING) Technique on a Rodent Model Using an Alginate Carrier |
Q92824731 | Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model |
Q47675000 | Single synchronous delivery of FK506-loaded polymeric microspheres with pancreatic islets for the successful treatment of streptozocin-induced diabetes in mice. |
Q57821796 | The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions |
Search more.